KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Non Operating Income: 2018-2025

Historic Non Operating Income for Castle Biosciences (CSTL) over the last 2 years, with Sep 2025 value amounting to $48,000.

  • Castle Biosciences' Non Operating Income was N/A to $48,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9 million, marking a year-over-year change of. This contributed to the annual value of -$2.9 million for FY2019, which is 978.31% down from last year.
  • Castle Biosciences' Non Operating Income amounted to $48,000 in Q3 2025, which was up 101.77% from -$2.7 million recorded in Q3 2019.
  • Castle Biosciences' Non Operating Income's 5-year high stood at $48,000 during Q3 2025, with a 5-year trough of $48,000 in Q3 2025.
  • For the 1-year period, Castle Biosciences' Non Operating Income averaged around $48,000, with its median value being $48,000 (2025).